Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Premier Research Group, the international pharmaceutical services group, has appointed Fabio Trave as its new executive director of medical affairs and strategic product development.
Subscribe to our email newsletter
In this position, Dr Trave will expand Premier Research’s capabilities in the area of drug development consulting and strengthen capabilities in the oncology therapeutic area. Dr Trave will be based in the company’s Milan office.
Dr Trave has received his medical degree from the University of Milan School of Medicine and completed his post-graduate training in clinical oncology at the Italian National Cancer Institute in Genoa and experimental therapeutics at Roswell Park Memorial Institute in Buffalo, New York.
Samer Kaba, vice president of global medical affairs and strategic product development at Premier Research, said: “We are very pleased to have Dr Trave join our medical affairs team of therapeutic experts. His global perspective and diverse expertise will strengthen our department and help us to expand our drug development and risk management consulting services to meet the evolving needs of our clients.”